You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on ...

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

On Wednesday 26 November 2025, nearly 150 students from five Luxembourg secondary schools took part in a meeting... }} ...

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...

The Trump administration plans a review of all refugees admitted to the U.S. during the Biden administration, according to a memo obtained Monday by The Associated Press. The ...

Officials in Utah, which has been battling a simmering outbreak in the southwestern part of the state, confirmed five new ...

The CDC monitors respiratory illness activity by looking at a range of diagnoses from emergency department (ED) visits, ...

Veterans aged 60 years and older who received a single dose of the respiratory syncytial virus (RSV) prefusion F3 (RSVPreF3) or RSV prefusion F (RSVpreF) vaccine remained protecte ...

VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from Invivyd’s proprietary antibody discovery technology ...

Some hospitals are reporting an uptick in respiratory syncytial virus hospitalizations in recent days, though national data — delayed by the federal shutdown — has yet to offer a clear picture.